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The human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) appear to have originated by cross-
species transmission of simian immunodeficiency virus (SIV) from asymptomatically infected African pri-
mates. Few of the SIVs characterized to date efficiently infect human primary lymphocytes. Interesting, two of
the three identified to infect such cultures (SIVsm and SIVcpz) have appeared in human populations as
genetically related HIVs. In the present study, we characterized a novel SIV isolate from an East African
monkey of the Cercopithecus genus, the l’hoest monkey (C. l’hoesti), which we designated SIVlhoest. This SIV
isolate efficiently infected both human and macaque lymphocytes and resulted in a persistent infection of
macaques, characterized by high primary virus load and a progressive decline in circulating CD4 lymphocytes,
consistent with progression to AIDS. Phylogenetic analyses showed that SIVlhoest is genetically distinct from
other previously characterized primate lentiviruses but clusters in the same major lineage as SIV from
mandrills (SIVmnd), a West African primate species. Given the geographic distance between the ranges of
l’hoest monkeys and mandrills, this may indicate that SIVmnd arose through cross-species transmission from
close relatives of l’hoest monkeys that are sympatric with mandrills. These observations lend support to the
hypothesis that the primate lentiviruses originated and coevolved within monkeys of the Cercopithecus genus.
Regarded in this light, lentivirus infections of primates not belonging to the Cercopithecus genus may have
resulted from cross-species transmission in the not-too-distant past.
The human immunodeficiency virus types 1 and 2 (HIV-1
and HIV-2) are lentiviruses that appear to have originated by
cross-species transmission from African primates (22, 25, 45).
Five distinct types of lentiviruses from nonhuman primates
have previously been molecularly characterized: SIVsm from
sooty mangabeys (Cercocebus atys) (7, 19, 37, 44), SIVagm
from the four species within the African green monkey super-
species (Cercopithecus aethiops) (3, 4, 8, 10, 11, 20, 28, 30, 38),
SIVsyk from Sykes monkeys (Cercopithecus mitis) (9, 21),
SIVmnd from mandrills (Mandrillus sphinx) (49), and SIVcpz
from chimpanzees (Pan troglodytes) (26, 27, 43, 50). It is cur-
rently believed that these characterized viruses may represent
just a small part of a very large family of primate lentiviruses.
Indeed, serologic surveys of other African primates have iden-
tified a number of other monkey species that have SIV-specific
antibodies (18, 33, 36, 40, 42). For example, SIV has recently
been isolated from a red-capped mangabey (Cercocebus tor-
quatus torquatus); partial characterization of this virus suggests
that it may represent a distinct (sixth) lineage, although anal-
ysis of the complete genome will be necessary to establish the
exact phylogenetic relationship between SIVrcm and other
primate lentiviruses (17).
Further study of the lentiviruses infecting nonhuman pri-
mates is important because it may provide insight into the
origins and evolution of HIV in humans. The phylogenetic
relationships among SIVsm and HIV-2 isolates clearly impli-
cate SIVsm as the proximal source of the HIV-2 epidemic in
West Africa (13, 14, 19, 37), but the origins of HIV-1 have not
been identified with certainty. A small number of pet chim-
panzees have been found to be infected with a virus (SIVcpz)
closely related to HIV-1 (26, 27, 43, 50), but the lack of sero-
logic evidence of SIVcpz infection in feral chimpanzee popu-
lations sheds doubt on whether this virus constitutes a natural
infection in this species (45). It is intriguing that SIVs which
are capable of infecting human peripheral blood mononuclear
cells (PBMC) are in a minority and at least for two of these
(SIVsm and SIVcpz), related HIVs (HIV-2 and HIV-1, respec-
tively) have been demonstrated in humans. The ability to infect
the CD41 lymphocytes of humans may thus be a prerequisite
for cross-species transmission to humans. While the ability of
these SIV strains to utilize human coreceptors is clearly one
mechanism, the accessory proteins Vpr and Vif also limit the
ability of some SIVs to replicate in human PBMC (46, 47).
Among the other species of African primates identified by
serologic surveys as harboring SIV are a number of species
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from the genus Cercopithecus, commonly called the guenons
(32, 34, 41). Cercopithecus monkeys are a diverse group of 25
species and as many as 70 subspecies of forest-dwelling mon-
keys that are distributed throughout subsaharan Africa (32, 34,
41). The most commonly known members are the four species
of African green monkeys (sabaeus monkeys, C. sabaeus; griv-
ets, C. aethiops; vervets, C. pygerythrus; and tantalus monkeys,
C. tantalus). Each of these four species harbors closely related
SIV strains, leading to the hypothesis that the primate lentivi-
ruses have coevolved with their host species (22, 25, 45). The
only other member of the guenons from which a novel SIV has
been characterized is the Sykes monkey from which SIVsyk (9,
21) was isolated. Despite the fact that both Sykes and African
green monkeys are members of the same genus, SIVsyk and
SIVagm are no more closely related to one another than to any
of the other characterized primate lentiviruses. Other Cerco-
pithecus monkeys for which SIV seropositivity has been ob-
served include DeBrazza monkeys (C. neglectus) (40), red-
tailed monkeys (C. ascanius schmidtii) (20), Hamlyn’s monkeys
(C. hamlyni) (40), and l’hoest monkeys (C. l’hoesti l’hoesti; 40).
The close phylogenetic relationships among these monkeys
and their widespread distribution across Africa, often in dis-
tinct habitats, suggest that the study of SIV in these species will
enrich our understanding of the evolution of the primate len-
tiviruses in general and of the origins of the AIDS epidemic in
humans in particular.
Molecular characterization of SIV strains from many of the
African monkeys has been hampered by the lack of availability
of samples from feral or wild-caught animals and the difficulty
in isolating the virus. An alternative source of samples are
wild-caught captive populations, such as those found at pri-
mate centers or zoo collections, although it is difficult to ex-
trapolate that seropositivity in these populations is indicative
of similar infection in free-living feral populations. In a sero-
logic survey of a troop of l’hoest monkeys (C. l’hoesti l’hoesti)
in the Portland Zoo, one wild-caught male with antibodies
cross-reactive with SIVmac was identified. Here we describe
the isolation of SIV from PBMC of this seropositive l’hoest
monkey by cocultivation with the human T-cell line, Molt4
Clone 8 (M4C8). This isolate, designated SIVlhoest, has been
characterized and compared to other known SIV sequences.
MATERIALS AND METHODS
Virus isolation and infectivity studies. Virus was isolated from PBMC of a
male l’hoest monkey by coculture of phytohemagglutinin-stimulated PBMC with
M4C8 cells, using production of reverse transcriptase (RT) activity in the culture
supernatant as a measure of viral replication. Virus stocks were prepared from
these infected cells by filtration through a 0.45-mm-pore-size filter and cryopre-
served in the vapor phase of liquid nitrogen for use in subsequent infectivity
studies. These culture supernatants were used to infect M4C8 and CEMss cells
to establish a cell line for isolation of total genomic DNA for subsequent cloning
studies and for preparation of cell-free virus stocks for infectivity studies in vitro
and in macaques.
Animal infectivity studies. Four juvenile (simian retrovirus- and simian T-cell
leukemia virus type 1-free) pigtailed macaques (Macaca nemestrina) were inoc-
ulated intravenously with 1 ml of the uncloned SIVlhoest virus stock described
above. Macaques were handled in accordance with the guidelines of the NIH
Animal Care and Use Committee. Animals were subsequently monitored by
virus isolation, coculture of PBMC (at 1, 2, 3, 4, 8, 12, and 16 weeks), limiting
dilution infectivity assay of plasma (at 1, 2, 3, and 4 weeks), limiting dilution
coculture of disrupted lymph node cells with CEMss cells (at 1, 2, 4, and 16
weeks), and in situ hybridization (ISH) of lymph node biopsies for SIVlhoest
viral RNA expression. Antibody responses were monitored by Western blot
analysis, using SIVlhoest virus pelleted through sucrose as the viral antigen and
published Western blot procedures (24). Lymphocyte subsets (CD4, CD8, CD2,
and CD20) were analyzed at the same intervals as virus isolation assays from
PBMC, and hematological alterations were monitored by performing complete
blood counts.
PCR amplification and plasmid cloning. Total cellular DNA was extracted
from infected CEMss cells at 10 to 15 days postinfection. Degenerate primers
(LV1 and LV2 for the first round and LV3 and DDMY for the second round of
amplification) designed to PCR amplify a small portion of all lentivirus pol
sequences (15) were used to amplify a portion of pol from total cellular DNA.
The amplification conditions were as follows: one cycle at 94°C for 2 min, 37°C
for 2 min, and 72°C for 3 min, followed by 35 cycles at 94°C for 30 s, 55°C for 30 s,
and 72°C for 1 min. The resulting 120-bp fragment was cloned into the TA
plasmid vector (Invitrogen) and sequenced. A reverse primer was designed based
on this sequence and by using a conserved forward primer situated in the primer
binding site of SIVs (30), a 2.4-kb fragment was amplified using the following
PCR amplification conditions: 94°C for 30 s, 55°C for 30 s, and 72°C for 2 min.
This fragment was cloned into the plasmid vector pGEM-7Zf and subsequently
utilized as a probe for Southern blot hybridization and screening of a bacterio-
phage lambda library.
Bacteriophage lambda cloning. A variety of restriction enzymes were evalu-
ated by Southern blot hybridization of total DNA from infected CEMss cells
using the 2.4-kb gag-pol virus fragment described above as a probe. Based on this
analysis, SstI was chosen for full-length cloning since the proviral DNA did not
appear to contain any SstI sites. Total cellular DNA was digested to completion
with SstI, fractionated over a 20 to 60% sucrose gradient to obtain 9- to 20-kb
fragments, and ligated into SstI- and XhoI-cleaved arms of lGem12 (Promega,
Madison, Wis.). Ligation products were packaged in vitro (Gigapack Gold III;
Stratagene), titrated, and plated on bacteria (Escherichia coli K802). A total of
1.5 3 106 recombinant plaques were screened, using a horseradish peroxidase-
labeled 2.4-kb gag-pol fragment and a direct detection method and following the
manufacturer’s instructions (ECL Direct Detection; Amersham). One positive
clone (lSIVlhoest-P7) was detected and plaque purified. To facilitate sequence
analysis, three subgenomic clones were generated by digestion of the recombi-
nant lambda clone with SstI and BamHI and ligation into a pGEM-7Zf1 vector.
The complete SIVlhoest provirus, including flanking cellular sequences (a 14-kb
SstI fragment), was also subcloned into pGEM-7Zf to facilitate subsequent
transfection studies. Both strands of the virus were sequenced by a combination
of manual dideoxy sequencing using T4 sequenase (USB) and automated fluo-
rescent sequencing (Taq amplification/termination; Perkin Elmer Applied Bio-
systems) in an ABI 377. Nucleotide sequence analysis was performed by using
the GeneWorks (Oxford Molecular) and the Intelligenetics programs (Oxford
Molecular).
Sequence comparisons. The predicted protein sequences encoded by SIV
lhoest were compared to the following representatives of the major primate
lentivirus lineages: HIV-1 subtype A (isolate U455; GenBank accession no.
M62320), subtype B (BRU; K02013), and group O (ANT70; L20587); SIVcpz
strains Gab (X52154) and Ant (U42720); SIVsm (PBj; M31325); HIV-2 subtype
A (ROD; M15390) and subtype B (UC1; L07625); SIVagm from vervets (ver155;
M29975), grivets (gri-1; M58410), and tantalus monkeys (tan-1; U58991); SIVsyk
(173; L06042); and SIVmnd (GB1; M27470). Protein sequences were aligned
using CLUSTAL X (48) with minor subsequent adjustments using SEAVIEW
(12). Sites that could not be aligned unambiguously, as well as all sites for which
there was a gap in any of the sequences, were excluded from the analyses.
The extent of sequence difference, along the genome, between SIVlhoest and
other viruses was examined in a diversity plot in which protein sequences were
concatenated with segments encoded by overlapping genomic regions repre-
sented only once: for example, in the region of the Gag-Pol overlap, the amino
terminus of the Pol protein was excluded. The fractional amino acid sequence
difference was calculated for a window size of 200 residues, moved in steps of 10
residues.
The phylogenetic relationship of SIVlhoest to other primate lentivirus se-
quences was estimated from aligned Gag, Pol, and Env sequences and from
subregions within these alignments to check for evidence that SIVlhoest might
have a mosaic genome resulting from recombination during its ancestry. In the
absence of such evidence, a summary phylogeny was derived from a concate-
nated Gag-Pol-Env alignment (the amino terminus of the Pol protein was again
excluded) totaling 1,909 amino acids. Relationships were estimated by the neigh-
bor-joining and maximum likelihood methods. The neighbor-joining method,
with Kimura protein distances and 1,000 bootstrap replicates, was implemented
within the CLUSTAL X package (48). The maximum likelihood method was
implemented with PROTML (1) using the JTT model. The order of sequence
input was shuffled five times, with the same best tree being found each time.
Generation of ISH probes. PCR was used to amplify five 1.5- to 2-kb fragments
of the SIVlhoest provirus from the complete plasmid clone by using the following
primers, where the restriction sites (SstI and Csp45I) introduced to facilitate
cloning are underlined: 1F, (nucleotide [nt] 1018) 59-ttagagctcttgtgagaagtgtgtaa
ttctgat; 1R, (nt 2482) 59-tgattcgaatctgcttttgttggagcactctcc; 2F, (nt 2506) 59-atcga
gctcgagagcactggagacttacaggac; 2R, (nt 4505) 59-atcttcgaattcctttatgagcaggcaccca
tc; 3F, (nt 4529) 59-attgagctctaggaggtaatcaagaggtagacc; 3R, (nt 6487) 59-catttcg
aataattaacactgcatacttaacat; 4F, (nt 6502) 59-ttagagctcccaatactagcctctgggtcacga;
4R, (nt 8503) 59-atattcgaataattaacactgcatacttaacat; 5F, (nt 8527) 59-atcgagctctac
ttgtaatcatagggttaagag; 5R, (nt 9844) 59-taattcgaaactagcttgtactttctaacaatg.
These five fragments were cloned into pGEM-7Zf, the subsequent clones were
digested with SstI (antisense) and Csp45I (sense), and RNA was transcribed to
incorporate digoxigenin using Sp6 and T7 polymerase, respectively. The pooled
antisense probe was used to detect viral mRNA expression in lymph node biopsy
samples that were fixed in STRECKS fixative using previously described meth-
odology (24).
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Transfection and infectivity studies. Virus stocks were generated by transfec-
tion of 5 to 10 mg of either the lambda or plasmid clone into 293 cells by a
calcium phosphate-mediated procedure (CellPhect; Stratagene). The infectivity
of these filtered supernatants was evaluated by infection of CEMss cells, ma-
caque PBMC, and macaque monocyte-derived macrophages as previously de-
scribed (24).
Nucleotide sequence accession number. The complete sequence of SIVlhoest
has been submitted to GenBank under accession no. AF075269.
RESULTS
Infectivity and pathogenicity of SIVlhoest in vivo. SIVlhoest
was clearly distinct from other primate lentiviruses, such as
SIVagm, SIVsm, or HIV-1, since the Gag antigens in culture
supernatants of persistently infected cells did not cross-react
with a commercially available SIVmac p27 antigen capture
assay (Coulter Corp.). As a prelude to any in vivo character-
ization, the infectivity of SIVlhoest for macaque and human
PBMC was compared to that of representative members of the
SIVsm, SIVsyk, SIVagm, and HIV-1 lineage (Fig. 1). Like
SIVsmE543-3, SIVlhoest infected both human and macaque
PBMC efficiently. This contrasted with the restricted tropism
of SIVsyk for Sykes monkey PBMC (not shown), SIVagm for
macaque PBMC, and HIV-1 for human PBMC.
Infectivity in macaque PBMC is a prerequisite for a robust
infection in vivo but clearly is not predictive of pathogenicity
for that species. To evaluate the potential pathogenicity of
SIVlhoest, a cohort of four pigtailed macaques (M. nemestrina)
was inoculated intravenously with uncloned SIVlhoest. Since
this latter virus had been passaged twice through human T-cell
lines, which might produce attenuation, we also isolated virus
from a homogenate of cryopreserved spleen from the same
l’hoest monkey by short-term coculture with M4C8 cells (4
days) and subsequent infection of macaque PBMC. This virus
was designated SIVlhoest-S to distinguish it from the PBMC
isolate; four additional pigtailed macaques were inoculated
intravenously with this primary virus isolate.
Each of the macaques became persistently infected, as evi-
denced by isolation of virus from PBMC and lymph node
biopsies at multiple time points postinoculation (Table 1). The
macaques inoculated with the virus isolate from PBMC (ma-
caques 622, 623, 626, and 627) that was passaged twice in
human T-cell lines exhibited less-consistent virus isolation than
macaques inoculated with the splenic isolate (macaques 633,
634, 635, and 636), which is suggestive of some degree of viral
attenuation of the PBMC isolate. However, one of these (ma-
caques 622) exhibited the most profound and early CD4 de-
pletion of all the inoculated animals. Each macaque exhibited
an early decline in all lymphocyte subsets (CD4 subset shown
in Fig. 2A), reaching a lowest point at 1 week postinoculation.
Lymphopenia was coincident with peak levels of infectious SIV
in the plasma (1,000 50% tissue culture infectious doses/ml)
and a high proportion of SIV-expressing cells within lymph
nodes, as demonstrated by limiting dilution coculture of dis-
rupted lymph node cells with CEMss cells (1 in 1,000 cells).
High lymphoid virus expression was confirmed by ISH with
SIVlhoest-specific riboprobes (Fig. 3). The plasma viremia re-
solved by 3 weeks, with declining prevalence of SIV-expressing
cells in lymph nodes; this phase was associated with the onset
of massive lymphoid hyperplasia and the trapping of virions in
a pattern characteristic of the distribution of follicular den-
dritic cells in germinal centers (6). Subsequent fluorescence-
activated cell sorter analysis of lymphocyte subsets revealed a
gradual decline (2- to 10-fold) in the numbers of circulating
CD41 lymphocytes, similar to that observed in a cohort of six
pigtailed macaques inoculated with a pathogenic uncloned
SIVsm isolate (SIVsmE660; Fig. 2B). As was also observed
with SIVsmE660 (22), the severity of the CD4 decline in
FIG. 1. In vitro growth characteristics of SIVlhoest and other primate lenti-
viruses in human and macaque PBMC. The replication of SIVlhoest, SIVagm,
SIVsm, SIVsyk, and HIV-1 as assessed by RT activity in culture supernatant is
shown graphically for macaque (A) and human (B) PBMC. For this assay,
equivalent amounts (based on RT activity of stocks) of the following viruses were
used: SIVlhoest-P, SIVagm155-4, SIVsmE543-3, SIVsyk/cm173, and HIV-1IIIB.
Since RT activity was never observed in SIVsyk-infected cultures, the symbols
are superimposed by values for the negative control.
TABLE 1. Sequential virus isolation from PBMC and lymph nodes
of macaques inoculated with SIVlhoest isolates
Isolation of virus at indicated wk postinoculationa
Isolate
source Macaque 1 2 4 8 12 16 20 24 28 32 36 40
PBMC 622 11 11 11 1 1 11 1 2 2 1 1 1
623 11 11 11 2 2 11 2 2 2 2 1 2
626 11 11 11 1 2 12 2 2 2 2 2 2
627 11 11 11 1 2 11 1 1 1 2 1 2
Spleen 633 11 11 11 1 1 11 2 1 1 2 1 1
634 11 11 11 1 1 11 1 1 1 1 2 1
635 11 11 11 1 1 11 1 1 1 1 1 1
636 11 11 11 1 1 11 2 2 2 2 2 1
a Virus isolation from PBMC and lymph nodes as detected by RT activity in
culture supernatant within a 6-week period of coculture is indicated by a 1, and
inability to isolate virus is indicated by a 2.
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SIVlhoest-infected macaques varied considerably, from mild
to profound depletion. The macaque that exhibited the most
severe CD4 depletion (macaque 622) has also failed to gain
weight and exhibits mild anemia (hematocrit of 28%), thrombo-
cytopenia (,30,000 per ml), and periodic bouts of diarrhea.
Two other macaques currently exhibit mild weight loss in
association with peripheral CD4 lymphocytes of less than 500
per ml.
SIVlhoest is a novel member of the SIVmnd lineage. In
order to characterize SIVlhoest molecularly, we used degen-
erate primers to amplify a 120-bp fragment of the pol gene
from cellular DNA extracted from infected M4C8 cells. This
fragment was cloned, and based on the sequence, we designed
a reverse primer in pol that was used in combination with a
forward primer in the highly conserved primer binding site to
amplify and clone a 2.4-kb gag-pol fragment. This fragment was
used as a probe in a subsequent Southern blot hybridization to
identify restriction enzymes useful for cloning and as a probe
to identify proviruses within a bacteriophage lambda library
generated by SstI digestion of cellular DNA extracted from
infected M4C8 cells. One full-length clone, lSIVlhoest-P7 was
obtained and purified. lSIVlhoest-P7 was infectious after
transfection of M4C8 or CEMss cells and subsequent infection
of macaque and human PBMC. After being subcloned into
plasmid vectors, the proviral portion of the clone was se-
quenced in its entirety (9,957 nt) and compared to the se-
quences of other known primate lentiviruses.
The genomic organization of SIVlhoest was similar to that of
SIVagm, SIVmnd, and SIVsyk. Each of these viruses encodes
gag, pol, and env, as well as the accessory genes vif, vpr, tat, rev,
and nef, but lacks the additional genes vpu (found only among
the members of the HIV-1 and SIVcpz lineage) and vpx (spe-
cific to SIVsm, SIVmac, and HIV-2). The long terminal repeat
(LTR) of SIVlhoest (789 nt) contained all the characteristic
features of other primate lentivirus LTRs, including one
NF-kB site and two potential SP-1 binding sites (data not
shown). Comparisons of the predicted protein sequences en-
coded by the eight common genes revealed that SIVlhoest was
quite distinct from all other SIV (and HIV) isolates analyzed
to date, exhibiting at least 33% amino acid sequence difference
from representatives of each of the five lineages of primate
lentiviruses (Table 2). For the large genes gag, pol, and env, as
well as for vpr and tat, the SIVlhoest proteins were most similar
to those of SIVmnd, but for the vif, rev, and nef genes, the
distance between the SIVlhoest and SIVmnd proteins was sim-
ilar to that between SIVlhoest and other SIVs. The similarity
between SIVlhoest and SIVmnd is shown in an alignment of
the surface unit (SU) portion of the Env protein of these two
viruses (Fig. 4). Although scattered substitutions are evident
throughout gp120, many of the cysteine residues (asterisks)
and potential N-linked glycosylation sites were conserved and
regions such as the V3 loop analog and the CD4 binding
domain showed remarkable conservation. The sequence of the
envelope amplified from the spleen of the l’hoest monkey
(lhoest-S) had 95% identity with that of the infectious clone
(lhoest-7). These two envelope sequences are representative of
the two isolates used to inoculate the macaques. As expected
from other primate lentivirus envelopes, the V1 region was the
most variable, with characteristic threonine residues and inser-
tion/deletion polymorphism. In contrast, the CD4 binding do-
main was absolutely conserved and only one substitution was
observed in the V3 loop analog.
To examine the divergence of SIVlhoest from the other
primate lentiviruses in more detail, the extent of sequence
difference was determined for moving windows of 200 amino
acids. The resulting diversity plot confirmed that overall,
SIVlhoest is most similar to SIVmnd but in some segments
these two viruses are about as different from each other as they
are from other SIVs (Fig. 5). Furthermore, that plot showed
that the boundaries of these regions lie within genes, so that
each of the major genes (gag, pol, and env) includes segments
of both types. This variation in the extent of relative divergence
between SIVlhoest and SIVmnd (i.e., relative to the extent of
divergence from other SIVs) could indicate that the ancestors
FIG. 2. Characteristics of SIVlhoest infection of pigtailed macaques. (A) Kinetics of sequential alterations in CD4 lymphocytes in the peripheral blood during the
first 16 weeks postinoculation in eight inoculated macaques, where the open symbols and dotted lines indicate animals inoculated with the PBMC isolate and solid lines
and black symbols indicate animals inoculated with the splenic isolate. (B) Kinetics of mean CD4 lymphocyte numbers with standard deviations are compared between
SIVlhoest-inoculated macaques and a cohort of six macaques inoculated with SIVsmE660, demonstrating that SIVlhoest induces a profile in declining CD4 lymphocyte
numbers similar to that observed with an AIDS-inducing SIV isolate.
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of these viruses were generated by recombination of different
SIV lineages, as has been found for SIVagm from sabaeus
monkeys (29). To examine the evolutionary relationship of
SIVlhoest to the other primate lentiviruses, we generated
numerous phylogenetic trees derived from alignments of indi-
vidual gene products and from smaller regions defined by
consideration of the diversity plot (data not shown). These all
indicated a clustering of SIVlhoest with SIVmnd, though their
relative distances varied. Thus, these analyses provided no
evidence that recombination has played a significant role in the
evolution of SIVlhoest (or SIVmnd) and suggested that the
variation in the extent of relative divergence between SIVl-
hoest and SIVmnd reflects changes in rates of evolution spe-
cific to these viruses.
Since the SIVlhoest-SIVmnd clade was maintained across
all of the analyses, an overview of the phylogenetic relation-
ships between these viruses was obtained from an analysis of
an alignment of concatenated Gag-Pol-Env proteins, in which
SIVlhoest appears as a highly divergent member of the same
major lineage as SIVmnd (Fig. 6). The interpretation that
SIVlhoest and SIVmnd are members of the same clade is
dependent on the position of the root of the phylogenetic tree;
the tree shown in Fig. 6 has been midpoint rooted. The “pre-
cise” position of the root of the primate lentivirus tree is
problematic, since the nearest available outgroup sequences,
namely, lentiviruses from other mammalian hosts, are quite
distantly related. However, analyses using various such out-
groups suggest that the rooting shown in Fig. 6 is appropriate.
Importantly, none of our analyses using nonprimate lentivirus
outgroups ever placed the root in such a position as to disrupt
the SIVlhoest-SIVmnd clade. Thus, we conclude that
SIVlhoest and SIVmnd are both members, albeit distantly
FIG. 3. Kinetics of virus expression in lymph nodes by ISH. (A1 and A2) ISH of lymph node biopsy sample obtained 1 week postinoculation, demonstrating high
virus expression. Magnification, 36 (top) and 355 (bottom). (B1 and B2) Lymph node biopsy sample obtained 2 weeks after inoculation, showing a reduction in the
numbers of SIV-positive cells relative to that observed at 1 week. Magnification, 36 (top) and 355 (bottom). (C1 and C2) ISH of a lymph node biopsy sample obtained
4 weeks after inoculation, showing a further reduction in the numbers of SIV-positive cells, with diffuse hybridization localized in the crescentric distribution of follicular
dendritic cells within the germinal center consistent with trapping of immune complexes containing SIV on dendritic cells. Magnification, 36 (top) and 355 (bottom).
TABLE 2. Comparison of amino acid identity among primate
lentiviruses, demonstrating that SIVlhoest is distantly related
to SIVmnda
Comparisons of SIVlhoest and major SIV lineages
Gag Pol Vif Vpr Tat Rev Env Nef
SIVmnd 54 67 38 65 43 32 51 44
SIVsyk 48 51 31 21 31 19 35 40
SIVagm 49 57 41 42 41 32 36 41
SIVsm 49 58 30 42 35 30 35 43
SIVcpz 49 58 33 41 26 19 30 41
a Identities were calculated as described in the “Sequence comparisons” sec-
tion of Materials and Methods.
TABLE 3. Divergence of SIVlhoest and SIVmnd from members of
the African green monkey familya
% Identity within lineages for indicated protein:
Gag Pol Vif Vpr Tat Rev Env Nef
SIVagm 77 70 57 76 57 53 70 73
SIVcpz 68 74 57 64 58 54 51 53
a Identities were calculated as described in the “Sequence comparisons” sec-
tion of Materials and Methods.
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related, of the same major primate lentivirus lineage. Overall,
SIVlhoest and SIVmnd are rather more divergent from each
other than are SIVs from different species of African green
monkey (Table 3). The only other example of such high diver-
gence within a major lineage involves the SIVcpz-HIV-1 lin-
eage, where SIVcpz/Ant is almost as different from SIVcpz/Gab1
(Table 3) and HIV-1 as SIVlhoest and SIVmnd are from each
other.
DISCUSSION
It seems clear that HIV-1 originated through cross-species
transmission(s) in the recent past from a naturally infected
African primate, but the species involved remains open to
question. Therefore, further exploration of the nature of the
diversity among primate lentiviruses is necessary to elucidate
the origins and evolution of the human viruses. Now that we
have characterized SIVlhoest and examined the relationship
between it and the previously known primate lentiviruses, it is
clear that this particular virus is not the proximal source of
HIV-1. However, the phylogenetic position of SIVlhoest is
surprising and has implications for our understanding of pri-
mate lentivirus evolution. In particular, at first sight, the ge-
netic similarity between SIVlhoest and SIVmnd seems difficult
to explain.
While the phylogeny of the primate lentiviruses indicates
that there have been multiple cross-species transmissions (45),
there are also indications that some of the viruses have co-
FIG. 4. Comparison of the predicted protein sequence of the surface subunit (SU) of the envelope of SIVlhoest and SIVmnd reveals remarkable conservation of
cysteine residues and regions such as the V3 loop analog and CD4 binding domain. Conserved cysteines are indicated by p, and variable cysteine residues are indicated
by a p above the top sequence. Potential N-linked glycosylation sites are underlined. The predicted sequence of gp120 of the SIVlhoest-7 molecularly cloned virus
derived from a PBMC isolate is shown on the top (lhoest-7). Substitutions relative to this sequence in the predicted sequence of a clone of envelope amplified directly
from the spleen of this monkey (lhoest-S) and the SIVmnd/GB-1 clone are shown aligned below. Dots indicate amino acid identity at a residue, and a dash indicates
a gap introduced to optimize alignment. Variable regions analagous to those observed in HIV-1 and other SIVs are indicated, and the cleavage site for the
transmembrane glycoprotein (TM) is shown.
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evolved with their natural host species and thus that the group
as a whole may be quite ancient. The four species of African
green monkeys (vervets, grivets, and sabaeus and tantalus
monkeys) each harbor their own variants of SIVagm, while
SIVsyk and now SIVlhoest are rather more divergent viruses
from rather more divergent Cercopithecus species. It is tempt-
ing to speculate that these Cercopithecus SIVs represent the
vertical transmission “backbone” of the primate lentivirus phy-
logeny, with the other SIVs from more distantly related pri-
mates having all resulted from horizontal transmissions.
Whether this scenario is accurate, the comparatively close re-
lationship between SIVlhoest and SIVmnd seems most un-
likely to be a reflection of host-dependent viral evolution, since
the mandrill belongs to a genus (Mandrillus) quite distant from
the Cercopithecus genus, and so (at least) one of these viruses
is likely the result of cross-species transmission. There is accu-
mulating evidence that such transfer of SIV does occur natu-
rally between different species of monkeys that share a com-
mon habitat in the wild. For example, the sabaeus subtype of
SIVagm has been identified in wild-caught patas monkeys
(Erythorocebus patas) in West Africa (5) and the vervet subtype
of SIVagm has been found in a yellow baboon (Papio hama-
dryas cynocephalus) in Tanzania (29). However, mandrills are
restricted to the west coastal region of central Africa around
Gabon, whereas l’hoest monkeys inhabit a localized area of cen-
tral Africa more than 1,000 km to the east (Fig. 7) (32, 34, 42).
The geographical separation of l’hoest monkeys and man-
drills implies that neither could be the immediate source of
virus for the other. However, close relatives of l’hoest monkeys
are found in regions of west central Africa overlapping the
mandrill range (Fig. 7). Preussis monkeys (C. preussi preussi
FIG. 5. Diversity plot comparing SIVlhoest with representatives of each of the five major lineages of primate lentiviruses, i.e., SIVmnd, SIVsyk, SIVsm, SIVcpz,
and SIVagm (SIVver). Protein sequence difference is plotted for windows of 200 amino acids moved in steps of 10.
FIG. 6. Phylogenetic relationship of SIVlhoest to other primate lentiviruses.
The tree was derived by maximum likelihood analysis of a concatenated Gag-
Pol-Env protein alignment (see text for details). A tree derived by neighbor-
joining analysis differed in no significant way. Stars indicate that the clade to the
right was found in 100% of bootstrap replicates of the neighbor-joining analysis.
Horizontal branch lengths are drawn to scale, with the bar indicating 0.1 amino
acid replacement per site.
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and insularis) from Cameroon and Bioko Island and sun-tailed
monkeys (C. solatus) from Gabon are sufficiently similar to
l’hoest monkeys that they have been considered by some to be
a subspecies of C. lhoesti. Furthermore, at least one of these
species, C. solatus, has serologic evidence of SIV infection
(25a). We therefore hypothesize that SIVmnd infection of
mandrills resulted from cross-species transmission of SIV from
one of these relatives of the l’hoest monkey. This direction of
the transmission, rather than from mandrill to the l’hoest mon-
key, is consistent with the Cercopithecus origin of primate len-
tiviruses suggested above and is supported by the apparently
low rate of SIV seroprevalence in wild mandrills. Only two
seropositive wild-caught mandrills have been reported, and the
only existing clone came from one of two seropositive founders
of a colony in Gabon. Although SIVmnd is now prevalent
within this colony, all of the circulating viruses appear to be
highly related, suggesting subsequent transmission of this virus
within the colony (16, 39). It will be interesting to determine
whether feral mandrills from other locations also harbor
SIVmnd.
Consistent with the proposed ancient relationship between
primate lentiviruses and their respective natural hosts, SIVs
appear to result in an asymptomatic infection in their natural
host species (e.g., SIVsm in sooty mangabeys or SIVagm in
African green monkeys) (24). However, AIDS may result upon
experimental infection of other primates, particularly ma-
caques (2, 7, 22, 24, 35). In the present study, SIVlhoest-
infected macaques demonstrated many of the virologic, immu-
nologic, and clinical characteristics of early infection of
macaques with pathogenic isolates of SIVsm, SIVmac, or
SIVagm. Such characteristics included (i) high viral expression
in lymphoid tissues in the primary phase of infection, (ii) high
primary plasma viremia, (iii) subsequent lymphadenopathy
and trapping of viral RNA in germinal centers in a follicular
dendritic cell pattern, (iv) declining peripheral CD4 lympho-
cyte numbers, (v) persistent PBMC-associated viremia, and
(vi) thrombocytopenia and weight loss in one macaque. Al-
though these animals have not been infected for a sufficient
period of time to become symptomatic, the virologic and clin-
ical features of infection are consistent with progression to
AIDS. Moreover, SIVlhoest appears to be directly pathogenic
for macaques without adaptation by prior macaque passage.
The ability of SIVlhoest to infect human PBMC in vitro at
least as efficiently as it infects macaque PBMC suggests that
this virus has the potential to infect human populations. Such
cross-species transmission to humans has already been ob-
served for the SIVsm isolate that is now circulating among
human populations as HIV-2 (13, 14). While the ability of this
virus to infect human PBMC may not be predictive of virulence
in humans, serologic surveys of humans in regions near the
habitat of l’hoest monkeys are necessary to evaluate this pos-
sibility. These highly specialized forest dwellers have consider-
ably less contact with humans than species such as sooty
mangabeys. However, the continued expansion of human pop-
ulations and encroachment upon the habitats of primates such
as the l’hoest monkey may amplify the risk for such an event in
the future.
FIG. 7. A schematic view of Africa, showing the ranges occupied by l’hoest monkeys (C. l’hoesti l’hoesti) and their close relatives, preussis monkeys (C. preussi
preussi) and suntailed monkeys (C. solatus); the distribution of mandrills (Mandrillus sphinx) is indicated by cross-hatching. A representative l’hoest monkey is shown.
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